Related Experiment Video
Updated: Sep 15, 2025
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Early alterations in nutritional indices in metabolic dysfunction-associated steatotic liver disease-related
Teruki Miyake1, Shinya Furukawa2, Osamu Yoshida1
1Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Background And Aim:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is primarily driven by relative overnutrition. Dietary restrictions and weight loss through exercise are known to improve this condition. However, as MASLD progresses, adequate nutritional intake is required to prevent decompensated cirrhosis. Therefore, appropriate nutritional assessment tools are needed to guide the transition from dietary restriction to adequate nutritional intake. However, early risk indicators of malnutrition in MASLD, particularly before decompensated cirrhosis develops, remain unclear. This study aimed to explore nutritional markers indicative of deterioration in MASLD with cirrhosis.
Methods:
This cross-sectional study included 154 patients (aged 18-79 years) diagnosed with MASLD by liver biopsy between October 2007 and June 2024 at Ehime University Hospital and received nutritional assessments during hospitalization.
Results:
The Royal Free Hospital Nutritional Prioritizing Tool classified all patients as low risk. Multivariate analysis, adjusted for age, sex, body mass index, creatinine levels, and nonalcoholic fatty liver disease activity score, identified lower albumin, lower cholinesterase, higher hemoglobin A1c, lower total cholesterol, and lower low-density (LDL) cholesterol as independently associated with advanced fibrosis. However, no significant differences were observed in body composition, nutritional intake, and non-protein respiratory quotients.
Conclusions:
Blood indices reflecting protein syntheses, including albumin and cholinesterase, were useful makers for comprehending the change in nutritional status in MASLD-related cirrhosis. Clinicians should consider these markers when initiating timely changes in nutritional interventions for MASLD-related cirrhosis.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
01:30Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...